Behavioral and psychological symptoms of dementia (BPSD) are common in Alzheimer's disease (AD), yet their mechanisms remain unclear.
Objective
We aim to explore the possible neurophysiological mechanisms of BPSD using high temporal resolution electroencephalography (EEG) microstate technology, laying the foundation for clinical evaluation and subsequent treatment.
Methods
We enrolled 52 AD patients (25 with BPSD, 27 without) and 29 age- and gender-matched healthy controls (HC). All participants underwent various neuropsychological assessments and resting-state EEG recordings. Resting-state EEG data were analyzed employing microstate analysis techniques, with a focus on four key microstate parameters: duration, occurrence, coverage, and transition probability. Inter-group comparisons were performed using post-hoc tests, with statistical significance determined through False Discovery Rate (FDR) correction. Furthermore, the correlations between the indicators and neuropsychological assessment scores were analyzed.
Results
Compared to the HC and non-BPSD groups, the BPSD group showed an increase in the transition rate from microstate A to microstate C. Compared to the HC group, the BPSD group showed an extension in the duration of microstate A and a decrease in the frequency of microstate D. Compared to the HC group, the non-BPSD group showed prolonged durations (A, B, mean) and reduced occurrences (C, D, mean).The partial correlation analysis with years of education as a covariate showed that in the BPSD group, the duration of microstate A was correlated with the severity of the Neuropsychiatric Inventory (NPI) and the Hamilton Anxiety Scale (HAMA).
Conclusions
AD with and without BPSD exhibits different altered brain dynamics.
ChenYDangMZhangZ. Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns. Mol Neurodegener2021; 16: 38.
2.
SerraLBruschiniMDi DomenicoC, et al.Behavioral psychological symptoms of dementia and functional connectivity changes: a network-based study. Neurobiol Aging2020; 94: 196–206.
3.
WattJAPorterJTavilsupP, et al.Guideline recommendations on behavioral and psychological symptoms of dementia: a systematic review. J Am Med Dir Assoc2024; 25: 837–846.e821.
4.
DevanandDPLeeSHueyED, et al.Associations between neuropsychiatric symptoms and neuropathological diagnoses of Alzheimer disease and related dementias. JAMA Psychiatry2022; 79: 359–367.
5.
KimBNohGOKimK. Behavioural and psychological symptoms of dementia in patients with Alzheimer's disease and family caregiver burden: a path analysis. BMC Geriatr2021; 21: 160.
6.
BottoRCallaiNCermelliA, et al.Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline. Neurol Sci2022; 43: 4107–4124.
7.
FullerJTChoudhuryTKLoweDA, et al.Hallucinations and delusions signal Alzheimer's associated cognitive dysfunction more strongly compared to other neuropsychiatric symptoms. J Gerontol B Psychol Sci Soc Sci2020; 75: 1894–1904.
8.
DevanandDP. Management of neuropsychiatric symptoms in dementia. Curr Opin Neurol2023; 36: 498–503.
9.
BoublayNSchottAMKrolak-SalmonP. Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer's disease: a review of 20 years of research. Eur J Neurol2016; 23: 1500–1509.
10.
JonesSADe MarcoMMancaR, et al.Altered frontal and insular functional connectivity as pivotal mechanisms for apathy in Alzheimer's disease. Cortex2019; 119: 100–110.
11.
QianWFischerCEChurchillNW, et al.Delusions in Alzheimer disease are associated with decreased default mode network functional connectivity. Am J Geriatr Psychiatry2019; 27: 1060–1068.
12.
WangXRenPMapstoneM, et al.Identify a shared neural circuit linking multiple neuropsychiatric symptoms with Alzheimer's pathology. Brain Imaging Behav2019; 13: 53–64.
13.
BalthazarMLPereiraFRLopesTM, et al.Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network. Hum Brain Mapp2014; 35: 1237–1246.
14.
HolmgrenSAnderssonTBerglundA, et al.Neuropsychiatric symptoms in dementia: considering a clinical role for electroencephalography. J Neuropsychiatry Clin Neurosci2022; 34: 214–223.
15.
KhannaAPascual-LeoneAMichelCM, et al.Microstates in resting-state EEG: current status and future directions. Neurosci Biobehav Rev2015; 49: 105–113.
16.
LiuFFuhJLPengCK, et al.Phenotyping neuropsychiatric symptoms profiles of Alzheimer's disease using cluster analysis on EEG power. Front Aging Neurosci2021; 13: 623930.
17.
ShimYSShinHE. Analysis of neuropsychiatric symptoms in patients with Alzheimer's disease using quantitative EEG and sLORETA. Neurodegener Dis2020; 20: 12–19.
18.
BritzJVan De VilleDMichelCM. BOLD Correlates of EEG topography reveal rapid resting-state network dynamics. Neuroimage2010; 52: 1162–1170.
19.
JackCRJrAndrewsJSBeachTG, et al.Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's association workgroup. Alzheimers Dement2024; 20: 5143–5169.
20.
MorrisJC. The clinical dementia rating (CDR): current version and scoring rules. Neurology1993; 43: 2412–2414.
21.
KatzmanRZhangMYOuang YaQ, et al.A Chinese version of the Mini-mental state examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol1988; 41: 971–978.
22.
BallardCGMargallo-LanaMFosseyJ, et al.A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. J Clin Psychiatry2001; 62: 631–636.
23.
LyketsosCGLopezOJonesB, et al.Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA2002; 288: 1475–1483.
24.
CummingsJLMegaMGrayK, et al.The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology1994; 44: 2308–2314.
25.
NasreddineZSPhillipsNABédirianV, et al.The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc2005; 53: 695–699.
26.
MaierWBullerRPhilippM, et al.The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord1988; 14: 61–68.
27.
WangXMMaHYZhongJ, et al.A Chinese adaptation of six items, self-report Hamilton depression scale: factor structure and psychometric properties. Asian J Psychiatr2022; 73: 103104.
28.
DelormeAMakeigS. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods2004; 134: 9–21.
29.
Pion-TonachiniLKreutz-DelgadoKMakeigS. ICLabel: an automated electroencephalographic independent component classifier, dataset, and website. Neuroimage2019; 198: 181–197.
30.
MilzPFaberPLLehmannD, et al.The functional significance of EEG microstates–associations with modalities of thinking. Neuroimage2016; 125: 643–656.
31.
AsakageSNakanoT. The salience network is activated during self-recognition from both first-person and third-person perspectives. Hum Brain Mapp2023; 44: 559–570.
32.
InceSStewardTHarrisonBJ, et al.Subcortical contributions to salience network functioning during negative emotional processing. Neuroimage2023; 270: 119964.
33.
LianHLiYLiY. Altered EEG microstate dynamics in mild cognitive impairment and Alzheimer's disease. Clin Neurophysiol2021; 132: 2861–2869.
34.
ZhangHPengBLiuY, et al.Altered microstate C and D dynamics in high social anxiety: a resting-state EEG study. Front Psychol2025; 16: 1581517.
35.
ThiriouxBLangbourNBokamP, et al.EEG Microstate co-specificity in schizophrenia and obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci2024; 274: 207–225.
36.
SiafarikasNAlnæsDMonereo-SanchezJ, et al.Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia. Int Psychogeriatr2021; 33: 1217–1228.
37.
ZhaoZRanXWangJ, et al.Common and differential EEG microstate of major depressive disorder patients with and without response to rTMS treatment. J Affect Disord2024; 367: 777–787.
38.
XueRLiXDengW, et al.Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression. Psychol Med2024; 54: 3036–3043.
39.
ZhaoKXieHFonzoGA, et al.Dementia subtypes defined through neuropsychiatric symptom-associated brain connectivity patterns. JAMA Netw Open2024; 7: e2420479.
40.
ZhaoQSangXMetmerH, et al.Functional segregation of executive control network and frontoparietal network in Alzheimer's disease. Cortex2019; 120: 36–48.
41.
SmailovicUKoenigTLaukkaEJ, et al.EEG Time signature in Alzheimer s disease: functional brain networks falling apart. Neuroimage Clin2019; 24: 102046.
42.
YanYGaoMGengZ, et al.Abnormal EEG microstates in Alzheimer's disease: predictors of beta-amyloid deposition degree and disease classification. Geroscience2024; 46: 4779–4792.
43.
TaitLTamagniniFStothartG, et al.EEG Microstate complexity for aiding early diagnosis of Alzheimer's disease. Sci Rep2020; 10: 17627.
44.
SoniSMuthukrishnanSPSoodM, et al.Hyperactivation of left inferior parietal lobule and left temporal gyri shortens resting EEG microstate in schizophrenia. Schizophr Res2018; 201: 204–207.
